Dosage

Reported ranges, every compound

One table: the range each compound's best source states, the kind of source, the date it was read, and the link to that compound's dosage page.

• Reference table

  Peptide Dosage Chart: Reported Ranges by Compound, With Sources

  One row per compound: the reported dose range as the strongest source states it, the kind of source, the date read, and a link to each compound's page.

Per-compound dosage calculators

Each page is the reconstitution calculator pre-set for one compound, plus its concentration reference and syringe-unit chart. Concentration math, not a dosing table.

• 5-Amino-1MQ Dosage Calculator

  Pre-set to the 50 mg, 100 mg vials, with the concentration table and the U-100 unit chart.

• AOD-9604 Dosage Calculator

  Pre-set to the 2 mg, 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• ARA-290 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• BPC-157 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Cagrilintide Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Cartalax Dosage Calculator

  Pre-set to the 10 mg, 20 mg vials, with the concentration table and the U-100 unit chart.

• CJC-1295 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• CJC-1295 + Ipamorelin Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• DSIP Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Epithalon Dosage Calculator

  Pre-set to the 10 mg, 50 mg vials, with the concentration table and the U-100 unit chart.

• Follistatin 344 Dosage Calculator

  Pre-set to the 1 mg, 2 mg, 5 mg vials, with the concentration table and the U-100 unit chart.

• GHK-Cu Dosage Calculator

  Pre-set to the 50 mg, 100 mg vials, with the concentration table and the U-100 unit chart.

• GHRP-2 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• GHRP-6 Dosage Calculator

  Pre-set to the 2 mg, 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Glutathione Dosage Calculator

  Pre-set to the 200 mg, 600 mg, 1000 mg, 1500 mg, 2000 mg vials, with the concentration table and the U-100 unit chart.

• Gonadorelin Dosage Calculator

  Pre-set to the 2 mg, 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Hexarelin Dosage Calculator

  Pre-set to the 2 mg, 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• HGH Fragment 176-191 Dosage Calculator

  Pre-set to the 2 mg, 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• IGF-1 LR3 Dosage Calculator

  Pre-set to the 0.1 mg, 1 mg vials, with the concentration table and the U-100 unit chart.

• Ipamorelin Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Kisspeptin-10 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• KPV Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• LL-37 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Mazdutide Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 15 mg vials, with the concentration table and the U-100 unit chart.

• Melanotan 1 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Melanotan II Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• MGF Dosage Calculator

  Pre-set to the 2 mg, 5 mg vials, with the concentration table and the U-100 unit chart.

• Mod GRF 1-29 Dosage Calculator

  Pre-set to the 2 mg, 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• MOTS-c Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• N-Acetyl Selank Amidate Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• NA-Semax Amidate Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 30 mg vials, with the concentration table and the U-100 unit chart.

• NAD+ Dosage Calculator

  Pre-set to the 100 mg, 500 mg, 750 mg, 1000 mg vials, with the concentration table and the U-100 unit chart.

• Oxytocin Dosage Calculator

  Pre-set to the 2 mg, 5 mg vials, with the concentration table and the U-100 unit chart.

• PE-22-28 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• PEG-MGF Dosage Calculator

  Pre-set to the 2 mg, 5 mg vials, with the concentration table and the U-100 unit chart.

• Pinealon Dosage Calculator

  Pre-set to the 10 mg, 20 mg vials, with the concentration table and the U-100 unit chart.

• PT-141 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Retatrutide Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 20 mg vials, with the concentration table and the U-100 unit chart.

• Selank Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Semaglutide Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Semax Dosage Calculator

  Pre-set to the 10 mg, 30 mg vials, with the concentration table and the U-100 unit chart.

• Sermorelin Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• SLU-PP-332 Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 20 mg vials, with the concentration table and the U-100 unit chart.

• SS-31 Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 50 mg vials, with the concentration table and the U-100 unit chart.

• Survodutide Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 15 mg vials, with the concentration table and the U-100 unit chart.

• TB-500 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Tesamorelin Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Thymalin Dosage Calculator

  Pre-set to the 5 mg, 10 mg, 20 mg vials, with the concentration table and the U-100 unit chart.

• Thymosin Alpha-1 Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Thymulin Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• Tirzepatide Dosage Calculator

  Pre-set to the 10 mg, 15 mg, 30 mg vials, with the concentration table and the U-100 unit chart.

• VIP Dosage Calculator

  Pre-set to the 5 mg, 10 mg vials, with the concentration table and the U-100 unit chart.

• 

  Pillar F — retatrutide (retatrutide cycle)

  Retatrutide Cycle Length: What the Trials Ran

  Retatrutide has trial durations, not cycles: 48 weeks in phase 2, 80 to 104 in TRIUMPH, a withdrawal arm reporting in 2028, and the milligrams each course used.

• 

  Pillar F — label dose charts (glp-1 starting dose)

  GLP-1 Starting Dose: What Each Label Starts At

  Starting doses from the 2026 GLP-1 labels: tirzepatide 2.5 mg, semaglutide 0.25 mg weekly, the tablets, retatrutide's trial start, and the units on a vial.

• 

  Pillar F — label dose charts (glp-1 maximum dose)

  GLP-1 Maximum Dose: Label Ceilings and Trial Results

  Maximum doses from the 2026 GLP-1 labels — tirzepatide 15 mg, Wegovy 7.2 mg, Ozempic 2 mg — and what higher doses added to weight loss in the trials.

• 

  Pillar B — dosage by compound

  Peptide Dosage Chart: Reported Ranges by Compound, With Sources

  One row per compound: the reported dose range as the strongest source states it, the kind of source, the date read, and a link to each compound's page.

• 

  Pillar B — dosage by compound (thymulin)

  Thymulin Dosage: The 1980s Trials and Vial Units

  Thymulin dosage as published: the 1, 5 and 10 mg a day rheumatoid arthritis trials, the multiple sclerosis study, what a 5 or 10 mg vial holds, and units.

• 

  Pillar B — dosage by compound (NA-Semax amidate)

  N-Acetyl Semax Amidate Dosage: What the Record Holds

  N-acetyl Semax amidate dosage: no trial, no label, no registered study; the Semax figures it borrows, the molecule-count conversion, and units per vial.

• 

  Pillar F — dosage comparisons (CJC-1295 vs BPC-157)

  CJC-1295 vs BPC-157 Dosage: Two Different Records

  CJC-1295 vs BPC-157 dosage: per-kilogram trial doses for one, no reviewed figure for the other, how often each is cited, and units per vial at each strength.

• 

  Pillar B — dosage by compound (GHK-Cu pharmacokinetics)

  GHK-Cu Half-Life: What Has Been Measured, and What Has Not

  GHK-Cu half-life: no human or animal figure is published; one 1997 rat study saw GHK broken down fast. Plasma levels by age and the arithmetic of a dose.

• 

  Pillar B — dosage comparisons (BPC-157 vs GHK-Cu)

  BPC-157 vs GHK-Cu: Doses, Vials, Molecules and Evidence

  BPC-157 vs GHK-Cu side by side: microgram vs milligram amounts, 5 mg vs 50 mg vials, molecules per draw, half-life records, human trials and FDA status.

• 

  Pillar B — dosage comparisons (SS-31 vs MOTS-c)

  SS-31 vs MOTS-c: One Label, One Mouse Record, Compared

  SS-31 vs MOTS-c dosage: elamipretide's 40 mg label beside MOTS-c's mouse-only record, what each does in mitochondria, molecules per mg and units.

• 

  Pillar B — dosage by compound (GH secretagogues by sex)

  GH Peptide Dosage for Women: What the Trials Enrolled

  Tesamorelin, sermorelin, ipamorelin and CJC-1295 dosage for women: who the trials enrolled by sex, the one study that split results by sex, and the units.

• 

  Pillar B — dosage by compound (BPC-157 pharmacokinetics)

  BPC-157 Half-Life: The Rat and Dog Data, Read in Full

  BPC-157 half-life from the one published pharmacokinetic study: 15 minutes IV in rats, 5 in dogs, under 30 by injection, and no human measurement.

• 

  Pillar B — dosage by compound (PT-141 by sex)

  PT-141 Dosage for Men vs Women: The Label and the Trials

  PT-141 dosage by sex: the one label (Vyleesi, 1.75 mg, premenopausal women only) beside the trial record in men, 0.3 to 10 mg, with units per vial.

• 

  Pillar F — label dose charts (glp-1 maintenance dose)

  GLP-1 Maintenance Dose: What Each Label States and Trials

  GLP-1 maintenance doses from the 2026 US labels: Zepbound 5, 10 or 15 mg, Wegovy 1.7 or 2.4 mg up to 7.2 mg, and what the withdrawal trials found.

• 

  Pillar B — dosage comparisons (ahk-cu vs ghk-cu)

  AHK-Cu vs GHK-Cu: Doses, Molecules and the Evidence

  AHK-Cu vs GHK-Cu for dosing: one amino acid apart, molecules per milligram, the concentrations each was studied at, the human record, and units per vial.

• 

  Pillar F — dosage comparisons (tesamorelin vs retatrutide)

  Tesamorelin vs Retatrutide Dosage: Daily Label, Weekly Trial

  Tesamorelin vs retatrutide dosage: a daily labelled GHRH drug for visceral fat against a weekly triple agonist in trials, their figures, and units per vial.

• 

  Pillar F — dosage comparisons (AOD-9604 vs retatrutide)

  AOD-9604 vs Retatrutide Dosage: Two Obesity Programmes

  AOD-9604 vs retatrutide dosage: a growth-hormone fragment whose obesity programme ended in 2007 against a weekly triple agonist in phase 3, and units per vial.

• 

  Pillar F — dosage comparisons (5-Amino-1MQ vs AOD-9604)

  5-Amino-1MQ vs AOD-9604 Dosage: Two Fat-Loss Records

  5-Amino-1MQ vs AOD-9604 dosage: a small molecule with mouse data only against a growth-hormone fragment with six oral and IV trials, and units per vial.

• 

  Pillar F — dosage comparisons (sermorelin vs BPC-157)

  Sermorelin vs BPC-157 Dosage: Two Records Side by Side

  Sermorelin vs BPC-157 dosage: an FDA-approved drug since withdrawn against a peptide never approved, the figures each source states, and units per vial.

• 

  Pillar B — dosage by compound (PE-22-28)

  PE-22-28 Dosage: The Mouse Data, Vendor Figures and Units

  PE-22-28 dosage: the one paper that dosed it (mice, 3 to 4 mcg/kg), what vendor pages cite, the paper's own inconsistency, and units for 5 and 10 mg vials.

• 

  Pillar B — dosage by compound (MGF)

  MGF Dosage: Animal Figures, a Failed Replication and Units

  MGF dosage: no human study, the rabbit bone figures (28.5 and 57 mcg/kg), two drug companies that could not reproduce its effect, vendor figures and units.

• 

  Pillar F — dosage comparisons (epitalon vs pinealon)

  Epitalon vs Pinealon Dosage: Published Amounts and Units

  Epitalon vs Pinealon dosage: the two human amounts on record for each, by eye, tongue and capsule, the vendor figures that exceed them, and units per vial.

• 

  Pillar B — dosage (tesamorelin cycle)

  Tesamorelin Cycle: How Long the Trials Ran, Week by Week

  Tesamorelin cycle length vs the record: every trial ran it daily without breaks for 2 weeks to 12 months, and fat returned when it stopped. Vials per course.

• 

  Pillar B — dosage (peptide cycle length)

  Peptide Cycle Length: What Trials and Labels Actually Ran

  Peptide cycle length by compound: how long each label and trial ran it, which ones used breaks, and how the online 4-to-12-week cycle figures compare.

• 

  Pillar B — dosage (GLP-1 missed dose)

  Missed GLP-1 Dose: Every Label's Rule and the Level Math

  What the Mounjaro, Zepbound, Ozempic and Wegovy labels state about a missed weekly dose, the June 2026 Wegovy restart change, and how far levels fall.

• 

  Pillar B — dosage by compound

  Thymosin Alpha-1 Dosage: The 1.6 mg Label Figure in Units

  The Zadaxin label's 1.6 mg twice-weekly figure and the markets it is approved in, the sepsis and hepatitis trial doses, and the U-100 units per research vial.

• 

  Pillar B — dosage by compound

  TB-500 Dosage: Reported Figures, Units and Water per Vial

  TB-500 has no label and no human trial of its own. The thymosin beta-4 trial doses, the 2026 registration and the vendor figures, dated, with units per vial.

• 

  Pillar B — dosage by compound

  Selank Dosage: The Russian Label, Trials and Syringe Units

  The Russian Selank nasal-drop label (drops, times a day, course), the three Russian trials, the figures vendor pages cite, and the units per research vial.

• 

  Pillar B — dosage by compound

  MOTS-c Dosage: What Sources State, per Day and in Units

  MOTS-c has no label and no published human dose. The one registration, the analog trial, the animal and vendor figures, dated, and the units per vial.

• 

  Pillar B — dosage by compound

  BPC-157 Dosage in Units: What Exists and What Does Not

  BPC-157 has no label and no published injectable dose. The registrations and papers counted, the 2026 FDA vote, the circulating figures, and units per vial.

• 

  Pillar F — dosage comparisons (semax vs selank)

  Semax vs Selank: Labels, Doses and Evidence Compared

  Semax vs Selank compared: two Russian nasal drops with a shared Pro-Gly-Pro tail, different strengths per drop, trial records and the 2026 FDA panel vote.

• 

  Pillar F — dosage comparisons (BPC-157 vs TB-500)

  BPC-157 vs TB-500 Dosage: Side by Side

  BPC-157 and TB-500 compared on the record: molecules, the one head-to-head study (32 rats), circulating amounts and what each looks like in units.

• 

  Pillar B — dosage comparison (SLU-PP-332 vs MOTS-c)

  SLU-PP-332 vs MOTS-c: Two 'Exercise Mimetics' Compared

  SLU-PP-332 vs MOTS-c: a small-molecule ERR agonist and a mitochondrial peptide, both called exercise mimetics. Mouse doses, molecules, vials, units, WADA.

• 

  Pillar B — dosage comparison (CJC-1295 vs IGF-1 LR3)

  CJC-1295 vs IGF-1 LR3: Dosage, Mechanism and Units

  CJC-1295 vs IGF-1 LR3: one raises the body's own IGF-1, the other is an IGF-1 analogue. The human record, the figures in circulation and both in units.

• 

  Pillar B — dosage comparison (AOD-9604 vs MOTS-c)

  AOD-9604 vs MOTS-c: Human Record, Dosage and Units

  AOD-9604 vs MOTS-c: a growth-hormone fragment tested in 893 people by mouth and vein, against a mitochondrial peptide never dosed in a published human study.

• 

  Pillar F — dose arithmetic (retatrutide units)

  Retatrutide Units to mg: A Syringe Reading, Both Ways

  Retatrutide in U-100 syringe units: what 10 to 120 units hold in mg at each research-vial concentration, every trial step as units, and the size of a misread.

• 

  Pillar B — dosage comparisons (mazdutide vs survodutide)

  Mazdutide vs Survodutide: Dose Ladders, mg and Units

  Two glucagon/GLP-1 dual agonists side by side: each trial's dose ladder, why their milligrams differ, the indirect comparisons, and units per dose.

• 

  Pillar B — dosage by compound

  Retatrutide Dosage: Trial Doses, Units per Vial and Water

  No approved retatrutide product exists. The phase 2 and TRIUMPH phase 3 doses, dated, and the same figures as syringe units at 5, 10 and 20 mg vials.

• 

  Pillar B — dosage by compound (retatrutide dose schedule)

  Retatrutide Dosing Schedule: Every Trial Ladder in Units

  The retatrutide escalation ladders each registered trial used, from 0.5 mg to 12 mg, what the phase 3 records leave out, and each step in syringe units.

• 

  Pillar B — dosage comparison (compounded tirzepatide vs Zepbound)

  Compounded Tirzepatide vs Zepbound: How the Doses Differ

  Zepbound's fixed 2.5 mg steps in 0.5 or 0.6 mL against compounded vials dosed in units at 5 to 20 mg/mL: concentrations, FDA dosing-error reports, vial rules.

• 

  Pillar B — dosage by compound (LL-37)

  LL-37 Dosage: Trial Concentrations, Tumour Doses and Units

  LL-37 dosage as the human record states it: 0.5 to 3.2 mg/mL on leg ulcers, 250 and 500 mcg per tumour, the 100–250 mcg online figures, and units per vial.

• 

  Pillar B — dosage comparison (hexarelin vs ipamorelin)

  Hexarelin vs Ipamorelin: Doses, Hormones and the Units

  Hexarelin vs ipamorelin by the record: per-kilogram trial doses, cortisol and prolactin, the 45% fade, molecules per mcg and the syringe units per vial.

• 

  Pillar B — dosage comparison (gonadorelin vs kisspeptin)

  Gonadorelin vs Kisspeptin: Doses, Order and the Units

  Gonadorelin vs kisspeptin: one is GnRH, the other acts on the neurons that release it. The test doses given to the same men, the pump figures and the units.

• 

  Pillar B — dosage comparison (5-amino-1MQ vs MOTS-c)

  5-Amino-1MQ vs MOTS-c: Molecules, Vials and Units

  5-Amino-1MQ vs MOTS-c: a small molecule and a peptide, both without a human dose. Mouse doses, molecules per mg, vial math, FDA and WADA status.

• 

  Pillar B — dosage by compound (PEG-MGF)

  PEG-MGF Dosage: What Exists, What Circulates, the Units

  PEG-MGF dosage: no human study has given it, the figures a 2026 review records from online protocols, how PEGylation changes the arithmetic, and units per vial.

• 

  Pillar F — dosage comparisons (Melanotan 1 vs Melanotan 2)

  Melanotan 1 vs Melanotan 2: Doses, Labels and the Units

  Melanotan 1 vs Melanotan 2 by the record: an approved 16 mg implant against three small trials at 0.025 mg/kg, relatives' labels, 28 case reports, units.

• 

  Pillar F — dosage comparisons (IGF-1 LR3 vs tesamorelin)

  IGF-1 LR3 vs Tesamorelin: Doses, Evidence and the Units

  IGF-1 LR3 vs tesamorelin: an IGF-1 analogue with no human study against a labelled GHRH analogue, doses 30 to 60 times apart, opposite feedback, units.

• 

  Pillar B — dosage by compound (hexarelin)

  Hexarelin Dosage: Trial Doses per Kilogram, and the Units

  Hexarelin dosage as the 1990s human trials gave it: 0.5 to 3 mcg/kg by injection, 20 to 60 mcg/kg intranasally, 20 and 40 mg by mouth, and the units per vial.

• 

  Pillar B — dosage by compound (thymalin)

  Thymalin Dosage: The Registered Label, Trials, Units

  Thymalin dosage from its Russian registration (5 to 20 mg a day, 30 to 100 mg a course), the one randomised trial's 10 mg, and the units per vial.

• 

  Pillar F — dose conversions (semaglutide to retatrutide)

  Switching From Semaglutide to Retatrutide: The Record

  Semaglutide to retatrutide: no conversion exists, the one head-to-head trial, the trials' 90-day rule, semaglutide's one-week half-life, and units.

• 

  Pillar B — dosage by route (PT-141 nasal)

  PT-141 Nasal Spray Dosage: The Trial Record and the Math

  PT-141 nasal spray dosage: the 7 to 20 mg intranasal doses Palatin tested, why it dropped the spray for blood pressure, and per-spray arithmetic.

• 

  Pillar F — dosage comparisons (kisspeptin vs PT-141)

  Kisspeptin vs PT-141: Doses, Receptors and the Evidence

  Kisspeptin-10 and PT-141 (bremelanotide) compared: two receptors, one labelled dose against none, the brain-imaging trials of each, and the syringe units.

• 

  Pillar F — dosage comparisons (GHRP-2 vs GHRP-6)

  GHRP-2 vs GHRP-6: Doses, GH Response and Appetite

  GHRP-2 and GHRP-6 compared: one ghrelin receptor, an approved diagnostic against none, relative GH potency, the appetite study, urine detection and units.

• 

  Pillar F — dosage comparisons (cagrilintide vs tirzepatide)

  Cagrilintide vs Tirzepatide: Doses, Trials and Units

  Cagrilintide and tirzepatide compared: an amylin analogue in trials against a labelled GIP and GLP-1 drug, dose ladders, the CagriSema head-to-head, and units.

• 

  Pillar F — dose arithmetic (semaglutide units)

  Semaglutide Dosage in Units: mg to Units Chart, Both Ways

  Semaglutide in syringe units at 2.5, 5, 7.5 and 10 mg/mL: each label step from 0.25 to 2.4 mg, the reverse lookup from 5 to 75 units, and the pen volumes.

• 

  Pillar A — dosage by route (oral tirzepatide)

  Oral Tirzepatide: Dosage, Sublingual Drops and the Evidence

  Oral and sublingual tirzepatide reported: no approved tablet, the one small human capsule study, the dog tablet study, and why an oral mg is not an injected mg.

• 

  Pillar F — dosage comparisons (mazdutide vs tirzepatide)

  Mazdutide vs Tirzepatide: Doses, Receptors and Results

  Mazdutide and tirzepatide dosing compared: 2 mg versus 2.5 mg starts, 4-week steps, trial figures, a network meta-analysis and the one study with both.

• 

  Pillar F — dosage comparisons (AOD-9604 vs tesamorelin)

  AOD-9604 vs Tesamorelin: Doses, IGF-1 and the Evidence

  AOD-9604 and tesamorelin compared: a GH fragment with no label against an approved GHRH analogue, their doses, what each does to IGF-1, and the syringe units.

• 

  Pillar F — label dose charts (zepbound dose chart)

  Zepbound Dose Chart: Every Label Step, Pen and Vial

  Zepbound and Mounjaro dose charts from the August 2026 US labels: the 2.5 mg start, 4-week steps, maintenance and 15 mg maximum, pens vs vials, missed doses.

• 

  Pillar F — label dose charts (wegovy dose chart)

  Wegovy Dose Chart: 0.25 mg to 7.2 mg, Plus Ozempic

  Wegovy dose chart from the June 2026 US label: the 16-week ladder, maintenance by indication, the 7.2 mg step, missed-dose restarts, and Ozempic's chart.

• 

  Pillar F — dose arithmetic (tirzepatide units)

  Tirzepatide Dosage in Units: mg to Units Chart, Both Ways

  Tirzepatide in syringe units at every concentration in use: each label step from 2.5 to 15 mg, the reverse lookup from 10 to 75 units, the arithmetic.

• 

  Pillar F — dosage comparisons (tesamorelin vs ipamorelin)

  Tesamorelin vs Ipamorelin: Doses, Receptors and Units

  Tesamorelin vs ipamorelin on the record: two receptors, one label against none, mg vs mcg figures, molecules per dose, half-lives and syringe units.

• 

  Pillar F — dosage comparisons (retatrutide vs semaglutide / Wegovy)

  Retatrutide vs Semaglutide Dosage: Ladders and Units

  Semaglutide's Wegovy label ladder and retatrutide's trial arms side by side: 0.25 mg against 2 mg first steps, 16-week climbs, results and syringe units.

• 

  Pillar F — dosage comparisons (CJC-1295 vs sermorelin)

  CJC-1295 vs Sermorelin: Doses, Half-Lives and Units

  CJC-1295 and sermorelin dosing compared: one historic label against two 2006 studies, half-lives of minutes and days, weekly totals and units per vial.

• 

  Pillar F — dosage comparisons (CJC-1295 vs ipamorelin)

  CJC-1295 vs Ipamorelin: Doses, Receptors and Units

  CJC-1295 and ipamorelin dosing compared: two receptors, a 40-minute GH peak against six days of release, per-kilogram study doses, vendor figures and units.

• 

  Pillar F — dosage comparisons (cagrilintide vs retatrutide)

  Cagrilintide vs Retatrutide: Doses Side by Side

  Cagrilintide vs retatrutide dosing: an amylin analogue at 0.3 to 4.5 mg against a triple agonist at 1 to 12 mg, trial results, the rat study and units.

• 

  Pillar F — dosage comparisons (survodutide vs tirzepatide)

  Survodutide vs Tirzepatide: Doses Side by Side

  Survodutide and tirzepatide dosing compared: a label ladder of 2.5 to 15 mg against trial doses of 0.3 to 6.0 mg, results, the planned switch study and units.

• 

  Pillar F — dosage comparisons (survodutide vs retatrutide)

  Survodutide vs Retatrutide: Doses Side by Side

  Survodutide and retatrutide dosing compared: trial dose ladders, starting steps of 0.3 mg and 2 mg, phase 3 results, and units per vial at each dose.

• 

  Pillar F — dosage comparisons (mazdutide vs retatrutide)

  Mazdutide vs Retatrutide: Doses Side by Side

  Mazdutide and retatrutide dosing compared: the same 2 mg first step, 4-week climbs to 6, 9 and 12 mg, trial results, approval status and units per vial.

• 

  Pillar F — dose conversions (tirzepatide to semaglutide)

  Switching From Tirzepatide to Semaglutide: The Record

  What the labels, the trial registry, an equivalence model and one published case state about moving from tirzepatide to semaglutide, with the washout.

• 

  Pillar B — dosage comparisons (tesamorelin vs CJC-1295)

  Tesamorelin vs CJC-1295: Doses Side by Side

  Tesamorelin and CJC-1295 dosing compared: labelled daily doses against per-kilogram trial doses, half-lives in minutes and days, weekly totals and units.

• 

  Pillar A — dosage by route (oral semaglutide)

  Oral Semaglutide Dosage: Tablet Strengths and Why mg Differ

  Rybelsus, Ozempic tablet and Wegovy tablet doses from the labels, why a tablet milligram is not an injected one, the switching rules, and sublingual forms.

• 

  Pillar A — dosage by route (oral BPC-157)

  Oral BPC-157 vs Injection: What the Dosage Record Shows

  Oral and injected BPC-157 on the record: rat doses by mouth, the one oral human registration, what bioavailability is and is not measured, and the arithmetic.

• 

  Pillar B — dosage timing (GLP-1)

  Best Time to Inject GLP-1s: What the Labels Say

  Time of day, missed-dose windows and day-change rules for semaglutide, tirzepatide and retatrutide, from the labels and trials, with the half-life behind each.

• 

  Pillar F — dosage comparisons (retatrutide vs tirzepatide)

  Retatrutide vs Tirzepatide Dosage: Two Ladders

  Tirzepatide's label ladder and retatrutide's trial arms side by side, in mg and syringe units, with the head-to-head trial's status. No verdict.

• 

  Pillar F — GLP-1 microdosing (index)

  GLP-1 Microdosing: The Numbers Side by Side

  Semaglutide, tirzepatide and retatrutide below their starting doses: label floors, the few trial arms under them, and why the syringe reading gets fragile.

• 

  Pillar F — compounded vial arithmetic (GLP-1 with B12, glycine, niacinamide, pyridoxine)

  Semaglutide or Tirzepatide With B12: The Vial Math

  Compounded GLP-1 vials with B12, glycine or niacinamide carry two concentrations. Units per dose and additive per dose, and what no trial has tested.

• 

  Pillar B — dosage by compound

  Oxytocin Dosage: Label Units, Nasal IU and Micrograms

  Oxytocin doses in three units: the label's milliunits per minute, 24 IU nasal research doses, and micrograms (1 IU ≈ 1.68 mcg), with units per vial.

• 

  Pillar B — dosage by compound

  Mazdutide Dosage: 4, 6 and 9 mg Trial Doses and Units

  Mazdutide's trial doses: 2 mg steps to 4 or 6 mg weekly in GLORY-1, 9 mg in GLORY-2, up to 16 mg in phase 1, with units for 5, 10 and 15 mg vials.

• 

  Pillar B — dosage by compound

  Gonadorelin Dosage: Pump Pulses, Test Doses and Units

  Gonadorelin's recorded doses: 5–20 mcg per pump pulse every 90 minutes, the 100 mcg IV test, 100–200 mcg on cattle labels, and units per vial size.

• 

  Pillar B — dosage by compound

  GHRP-2 Dosage: The 100 mcg Test Dose, Trial Doses and Units

  GHRP-2 (pralmorelin) in human studies: the 100 mcg IV diagnostic dose used in Japan, 0.3–3 mcg/kg a day under the skin in children, and units per vial.

• 

  Pillar B — dosage by compound

  Cartalax Dosage: What Is Recorded, and Units per Vial

  Cartalax (the AED tripeptide) has no indexed human dosing trial. What the cell studies used, what one protocol page states, and units for 10 and 20 mg vials.

• 

  Pillar B — dosage by compound (tirzepatide split dose)

  Tirzepatide Split Dose: Twice-Weekly Levels and Units

  What splitting a weekly tirzepatide dose into two injections does to blood levels, which presentations can be split, and the units each half reads at.

• 

  Pillar B — dosage by compound

  Melanotan 1 Dosage: Implant, Trial Doses and Units

  Melanotan 1 is afamelanotide: the 16 mg implant every two months on its label, the per-kilogram injection trials, the 250 mcg figure online and units per vial.

• 

  Pillar B — dosage by compound

  GHRP-6 Dosage: Test Doses, Trial Doses and Units

  GHRP-6's human doses: the 1 mcg/kg diagnostic test, 100–400 mcg/kg in the pharmacokinetic study, 5 mg IV in stroke trials, and units per vial.

• 

  Pillar B — dosage comparison (cjc-1295 dac vs no dac)

  CJC-1295 DAC vs No DAC: Molecule, Half-Life and Dosing

  How CJC-1295 with DAC and without it differ: the albumin-binding linker, an 8-day half-life against none published, weekly build-up and the same-vial units.

• 

  Pillar B — dosage by compound

  Survodutide Dosage: Trial Doses, Escalation and Units

  Survodutide's trial doses from 0.3 to 6.0 mg weekly, the week-by-week phase 2 escalation Boehringer posted, the phase 3 results and units per vial.

• 

  Pillar F — half-life (semaglutide)

  Semaglutide Half-Life: One Week, Five to Seven Weeks Out

  Semaglutide's half-life is about one week on every label. Why Ozempic says 5 weeks and Wegovy 5 to 7, the tablet against the injection, and the washout.

• 

  Pillar B — dosage by compound

  HGH Fragment 176-191 Dosage: Vendor Figures, No Human Trial

  HGH Fragment 176-191 has no human trial; its one in-vivo dose on record is a 1978 rat study. The vendor figures, that dose converted, and units per vial.

• 

  Pillar B — dosage by compound

  Follistatin 344 Dosage: What Exists Behind the Vial Figures

  No trial has injected follistatin protein into people. The gene-therapy doses, what black-market vials contained, the vendor figures and units per vial.

• 

  Pillar F — dose conversions (tirzepatide to retatrutide)

  Switching From Tirzepatide to Retatrutide: The Record

  No label, trial or conversion covers moving from tirzepatide to retatrutide. What the trial rules, the half-lives and the dose steps state, in units.

• 

  Pillar F — half-life (tirzepatide)

  Tirzepatide Half-Life: The Label Figures, Worked Through

  Tirzepatide's half-life on both current labels and in the phase 1 data, what remains a week after a dose, how it builds up, and the rules it explains.

• 

  Pillar F — half-life (retatrutide)

  Retatrutide Half-Life: What the Trials Measured

  Retatrutide's half-life of about 6 days rests on one phase 1b trial. The source, what remains after each week, and the studies with no posted results.

• 

  Pillar F — dosage comparisons (sermorelin vs ipamorelin)

  Sermorelin vs Ipamorelin Dosage: Units and Half-Lives

  Sermorelin vs ipamorelin dosage: the figures each source states, units per vial, 4-minute vs 2-hour half-lives, and why equal micrograms are not equal doses.

• 

  Pillar F — GLP-1 dosing questions (microdosing semaglutide)

  Semaglutide Microdosing: Sub-0.25 mg Amounts in Units

  Semaglutide microdosing in numbers: the 0.25 mg label floor, the trial arms that went below it, and 0.05 to 0.25 mg as syringe units per vial.

• 

  Pillar F — GLP-1 dosing questions (glp 1 dosage chart)

  GLP-1 Dosage Chart: Every Label Side by Side

  GLP-1 dosage chart from the current US labels: starting dose, steps, maximum, schedule and half-life for twelve products, plus units per dose in powder vials.

• 

  Pillar F — GLP-1 dosing questions (microdosing tirzepatide)

  Tirzepatide Microdosing: Sub-2.5 mg Amounts in Units

  Tirzepatide microdosing in numbers: the label's 2.5 mg floor, the one trial arm below it (1 mg, 26 weeks), and 0.5 to 2 mg as syringe units.

• 

  Pillar F — dosage comparisons (tesamorelin vs sermorelin)

  Tesamorelin vs Sermorelin: Doses, Half-Lives and Units

  Tesamorelin vs sermorelin compared on the record: labelled and trial doses, half-lives, molecules per milligram, legal status, and each figure as syringe units.

• 

  Pillar F — dose conversions (semaglutide to tirzepatide)

  Switching From Semaglutide to Tirzepatide: The Record

  What the labels, switching trials and an equivalence model state about moving from semaglutide to tirzepatide, dated, with the steps as syringe units.

• 

  Pillar B — dosage by compound

  VIP Peptide Dosage: Every Registered Dose Is a Drip

  Every registered human VIP dose is intravenous or inhaled, and measured in picomoles per kilogram per hour. Converted into micrograms and syringe units.

• 

  Pillar B — dosage by compound

  Pinealon Dosage: One Human Figure, and It Is a Capsule

  The only published human Pinealon amount is 100 mcg twice a day, taken by capsule. What the tagged trial states, what it omits, and the vial arithmetic.

• 

  Pillar B — dosage by compound

  ARA-290 Dosage: Milligrams a Vial Barely Covers

  ARA-290 is dosed in whole milligrams in four registered trials. What 1, 2, 4 and 8 mg a day mean for a 5 or 10 mg vial, and how few days one holds.

• 

  Pillar B — dosage by compound

  Semax Dosage: The Registered Drops and the Trials

  Semax is dosed as a percentage solution, not a vial. What the Russian registrations and the four tagged trials state, converted to mg/mL and syringe units.

• 

  Pillar B — dosage by compound

  IGF-1 LR3 Dosage: The Animal Figures and the Label

  Every published IGF-1 LR3 dose is an animal dose. What those studies state, what the approved IGF-1 label states, and both converted to syringe units.

• 

  Pillar B — dosage by compound

  Epithalon Dosage: The Extract, the Peptide, the Vial

  Most Epithalon dose claims come from Epithalamin, a pineal extract. What the two published human figures for the tetrapeptide state, and both in syringe units.

• 

  Pillar B — dosage by compound

  Melanotan II Dosage: The Phase I Figures, and the Units

  The three human Melanotan II studies all used 0.025 mg/kg, which is 1.75 mg at 70 kg. What they reported, what the approved relative's label says, and the math.

• 

  Pillar B — dosage by compound

  DSIP Dosage: The Trials in nmol/kg, Converted to Units

  Every human DSIP dose was intravenous, in nanomoles per kilogram. What the trials from 1981 to 2009 state, converted to micrograms and syringe units.

• 

  Pillar B — dosage by compound

  5-Amino-1MQ Dosage: The Mouse Studies, the Salt and Units

  Every published 5-Amino-1MQ dose is a mouse dose. What the three indexed papers state, the salt-form correction that moves every figure, and the vial math.

• 

  Pillar B — dosage by compound

  Tirzepatide Dosage: Label Steps, Units per Vial and Water

  What the Zepbound and Mounjaro labels and SURMOUNT-1 state for tirzepatide, dated, and the same figures as U-100 syringe units at each 10, 15 and 30 mg vial.

• 

  Pillar B — dosage by compound

  Tesamorelin Dosage: Label Daily Dose, Units and Water

  The three Egrifta labels' daily doses of 2, 1.4 and 1.28 mg and their reconstitution volumes, dated, plus the units for 5 mg and 10 mg research vials.

• 

  Pillar B — dosage by compound

  SS-31 Dosage Chart: The Forzinity Label, Trials and Units

  SS-31 is elamipretide, approved as Forzinity in 2025. The label's 40 mg daily dose, the trial and vendor figures, dated, with units for 5, 10 and 50 mg vials.

• 

  Pillar B — dosage by compound

  SLU-PP-332 Dosage: No Human Dose Exists, Only Mouse Figures

  Not a peptide, never given to a person: the mouse doses in the primary papers, their 70 kg equivalent, the figures vendor pages cite, and the vial arithmetic.

• 

  Pillar B — dosage by compound

  Sermorelin Dosage: Historic Label, Clinic Figures and Units

  Sermorelin's label was withdrawn in 2008. The Geref record, the trial regimen behind it and the clinic figures in circulation, dated, with units per vial.

• 

  Pillar B — dosage by compound

  Semaglutide Dosage Chart: Label Steps, Units and Water

  The Wegovy and Ozempic schedules as the 2026 labels state them, the STEP trial doses, and the figures as U-100 syringe units at 5 mg and 10 mg vials.

• 

  Pillar B — dosage by compound

  PT-141 Dosage: Label Figure, Trial Doses, Units per Vial

  What the Vyleesi label, the phase 3 trials and vendor pages state for PT-141 (bremelanotide), and the U-100 syringe units of each figure at every vial size.

• 

  Pillar B — dosage by compound

  NAD+ Dosage: Injection Figures, Sources and Units per Vial

  No NAD+ injection has an FDA label. This page reports the trial, registry, clinic and vendor figures with dates, and works the units per vial size.

• 

  Pillar B — dosage by compound

  KPV Dosage: Oral and Injectable Figures, Sources and Units

  KPV has no label, registered trial or human study. This page reports the mouse doses and the oral, injectable and topical vendor figures, with units per vial.

• 

  Pillar B — dosage by compound

  Kisspeptin-10 Dosage: The Trial Figures in mcg/kg and Units

  Kisspeptin-10 doses from human studies (IV bolus, IV and subcutaneous infusion, per kilogram), the figures vendor pages cite, and the syringe units per vial.

• 

  Pillar B — dosage by compound

  Ipamorelin Dosage: Trial vs Vendor Figures and Units

  Every human ipamorelin dose was intravenous, 3 to 100 mcg/kg or 0.03 mg/kg twice daily. This page reports those and the vendor figures, with units per vial.

• 

  Pillar B — dosage by compound

  Glutathione Dosage: Injection Figures and Units per Vial

  No FDA label exists for injectable glutathione. This page reports the compounding, trial and vendor figures with dates, and works the units for every vial size.

• 

  Pillar B — dosage by compound

  GHK-Cu Dosage: Topical vs Injectable Figures and Units

  GHK-Cu's human evidence is topical; the injectable figures are vendor conventions. This page reports both with dates and works the units per vial.

• 

  Pillar B — dosage by compound

  CJC-1295 Dosage: DAC vs No-DAC Figures and Units per Vial

  The two human CJC-1295 studies used the DAC form at 30 to 90 mcg/kg. This page reports them, the vendor figures for both forms, and the units per vial.

• 

  Pillar B — dosage by compound

  CJC-1295 Ipamorelin Dosage: Blend Figures and Units per Vial

  No trial has tested the CJC-1295 and ipamorelin blend. This page reports the vendor figures for each component, dated, and works the blend-vial arithmetic.

• 

  Pillar B — dosage by compound

  Cagrilintide Dosage: Trial Doses, Units per Vial and Water

  Cagrilintide has no label. The phase 2 and REDEFINE trial doses, dated, the pending FDA application, and the figures as syringe units at 5 and 10 mg vials.

• 

  Pillar B — dosage by compound

  AOD-9604 Dosage: The Six Trials' Doses and Units per Vial

  Six sponsor trials gave AOD-9604 by mouth at 0.25 to 54 mg and by vein at 25 to 400 mcg/kg, never under the skin; reported with dates and units per vial.